Cardinal Health was founded in 1971 and is headquartered in Dublin, US

Report incorrect company information

President, Global Commercial Solutions

Executive Vice President, Global Sourcing

President, Cardinal Health Specialty Solutions

Chief Executive Officer, Medical Segment

Chief Financial Officer

Executive Vice President, Strategy and Corporate Development

Report incorrect company information

Cardinal Health has an office in Dublin

Dublin, US (HQ)

7000 Cardinal Place

Report incorrect company information

Cardinal Health's revenue was reported to be $121.55 b in FY, 2016 which is a **18.5% increase** from the previous period.

USD | |
---|---|

## Revenue (Q3, 2018) | 101.5 b |

## Gross profit (Q3, 2018) | 5.4 b |

## Gross profit margin (Q3, 2018), % | 5.4% |

## Net income (Q3, 2018) | 1.4 b |

## EBIT (Q3, 2018) | 1.2 b |

## Market capitalization (23-May-2018) | 16.4 b |

## Closing share price (23-May-2018) | 52.7 |

## Cash (31-Mar-2018) | 2.2 b |

Cardinal Health's current market capitalization is $16.4 b.

Annual

usd | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|---|---|

## Revenue | 102.6 b | 107.6 b | 101.1 b | 91.1 b | 102.5 b | 121.5 b |

| 5% | (6%) | (10%) | 13% | 19% | |

## Cost of goods sold | 98.5 b | 103 b | 96.2 b | 85.9 b | 96.8 b | 115 b |

## Gross profit | 4.2 b | 4.5 b | 4.9 b | 5.2 b | 5.7 b | 6.5 b |

Quarterly

USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Revenue | 24.5 b | 22.2 b | 21.4 b | 24.1 b | 25.5 b | 25.4 b | 28.1 b | 31.4 b | 30.7 b | 32 b | 33.2 b | 31.8 b | 67.8 b | 101.5 b |

## Cost of goods sold | 23.3 b | 20.9 b | 20.1 b | 22.7 b | 24.1 b | 23.9 b | 26.5 b | 29.8 b | 29 b | 30.4 b | 31.5 b | 30.1 b | 64.3 b | 96 b |

## Gross profit | 1.3 b | 1.3 b | 1.3 b | 1.3 b | 1.5 b | 1.5 b | 1.6 b | 1.6 b | 1.7 b | 1.6 b | 1.6 b | 1.7 b | 3.5 b | 5.4 b |

| 5% | 6% | 6% | 6% | 6% | 6% | 6% | 5% | 6% | 5% | 5% | 5% | 5% | 5% |

Annual

usd | Y, 2010 | Y, 2011 | Y, 2012 | Y, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|---|---|---|---|

## Cash | 2.8 b | 1.9 b | 2.3 b | 1.9 b | 2.9 b | 4.6 b | 2.4 b |

## Accounts Receivable | 5.4 b | 6.5 b | 7.4 b | ||||

## Current Assets | 17.9 b | 21.8 b | 22 b | ||||

## PP&E | 1.5 b | 1.5 b | 1.8 b |

Quarterly

USD | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q2, 2018 | Q3, 2018 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|

## Cash | 2.8 b | 2.7 b | 3 b | 2.5 b | 2.9 b | 3.2 b | 3 b | 2.3 b | 2.6 b | 2 b | 1.9 b | 1.4 b | 1.2 b | 2.2 b |

## Accounts Receivable | 4.9 b | 4.9 b | 4.8 b | 5.7 b | 5.7 b | 6.1 b | 7 b | 7 b | 7.3 b | 7.7 b | 7.5 b | 7.5 b | 7.7 b | 7.7 b |

## Inventories | 7.3 b | 8.5 b | 8 b | 8.1 b | 9.4 b | 9.2 b | 9.8 b | 11 b | 10.9 b | 10.9 b | 11.9 b | 11.6 b | 12.1 b | 12 b |

## Current Assets | 16 b | 17.2 b | 16.9 b | 17.5 b | 19.2 b | 19.6 b | 21.2 b | 21.8 b | 22.3 b | 22.3 b | 23.2 b | 22.3 b | 25.2 b | 23.5 b |

Annual

USD | FY, 2014 | FY, 2015 | FY, 2016 |
---|---|---|---|

## Net Income | 1.2 b | 1.2 b | 1.4 b |

## Cash From Operating Activities | 2.5 b | 2.5 b | 3 b |

## Purchases of PP&E | (249 m) | (300 m) | (465 m) |

## Cash From Investing Activities | (850 m) | (849 m) | (4.1 b) |

Quarterly

USD | Y, 2018 |
---|---|

## Financial Leverage | 5.4 x |

Cardinal Health's Patients was reported to be 2 m in Y, 2016. Cardinal Health's Products Manufactured was reported to be 2.8 b in Y, 2016.

Y, 2013 | Y, 2014 | Y, 2015 | Y, 2016 | |
---|---|---|---|---|

## Patients | 1 m | 1.50 m | 1.80 m | 2 m |

## Pharmacies Served | 18 k | 19 k | 20 k | 25 k |

## Products | 30 k | 40 k | 40 k | 40 k |

## Products Manufactured | 2 b | 2.50 b | 2.80 b |

Acquired Company | Date | Deal Size |
---|---|---|

TelePharm (20) | September 01, 2016 | |

NaviHealth | August 25, 2015 | $410 m |

Outcomes Incorporated | July 16, 2015 | |

Cordis | March 02, 2015 | $2 b |

Access Closure | April 02, 2014 | $320 m |

AssuraMed | March 18, 2013 | |

Healthcare Solutions | June 10, 2010 | |

Carefusion | October 18, 2006 |

Report incorrect company information